Rapid evolution of the COVID-19 pandemic calls for a unified public health response
BioScience Trends. 2021; 15(4):196-200.
Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma
Qi FH, Tang W
BioScience Trends. 2021; 15(4):201-204.
Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19
Su J, Lu HZ
BioScience Trends. 2021; 15(4):205-210.
New progress in elucidating the relationship between cancer therapy and cardiovascular toxicity
Wu C, Lin DW, Ma F, Jiang F, Wang YS
BioScience Trends. 2021; 15(4):211-218.
The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database
SatoK, Mano T, Niimi Y, Iwata A, Toda T, Iwatsubo T
BioScience Trends. 2021; 15(4):219-230.
Anti-neuroinflammatory activity of Shenqi Fuzheng Injection and its main active constituents
Wang W, Zhang Z, Deng Y, Yang Z, Hou J, Long H, Lei M, Wu W
BioScience Trends. 2021; 15(4):231-239.
C-C chemokine receptor type 6 modulates the biological function of osteoblastogenesis by altering the expression levels of Osterix and OPG/RANKL
Li LS, Zhou J, Xu YP, Huang ZS, Zhang N, Qiu XM, Wang L
BioScience Trends. 2021; 15(4):240-248.
Replication Factor C4 in human hepatocellular carcinoma: A potent prognostic factor associated with cell proliferation
Chen P, Liu YY, Ma XC, Li QL, Zhang YF, Xiong QQ, Song TQ
BioScience Trends. 2021; 15(4):249-256.
Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures
Sawakami T, Karako K, Song PP, Sugiura W, Kokudo N
BioScience Trends. 2021; 15(4):257-261.
China should emphasize key issues inherent in rational medication management for the elderly
Tang Q, Wang C, Wu WH, Cao Y, Chen G, Lu J
BioScience Trends. 2021; 15(4):262-265.